Credit Suisse Reiterates “Outperform” Rating for Croda International (CRDA)
Croda International (LON:CRDA)‘s stock had its “outperform” rating restated by stock analysts at Credit Suisse in a report issued on Friday, American Banking and Market News reports. They currently have a GBX 2,850 ($46.97) price objective on the stock. Credit Suisse’s target price would suggest a potential upside of 18.16% from the stock’s previous close.
Shares of Croda International (LON:CRDA) traded up 0.29% during mid-day trading on Friday, hitting GBX 2412.00. 306,172 shares of the company’s stock traded hands. Croda International has a one year low of GBX 2205.00 and a one year high of GBX 2846.00. The stock has a 50-day moving average of GBX 2369. and a 200-day moving average of GBX 2499.63. The company’s market cap is £3.258 billion.
CRDA has been the subject of a number of other recent research reports. Analysts at UBS AG raised their price target on shares of Croda International from GBX 2,500 ($41.20) to GBX 2,515 ($41.45) in a research note to investors on Friday. They now have a “neutral” rating on the stock. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of Croda International in a research note to investors on Thursday. They now have a GBX 2,600 ($42.85) price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Croda International in a research note to investors on Wednesday. They now have a GBX 2,700 ($44.50) price target on the stock. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of GBX 2,607.95 ($42.98).
Croda International Plc is a marketing and technology company that produces and sells speciality chemicals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.